|
TOP STORY |
Functional Salivary Gland Regeneration by Transplantation of a Bioengineered Organ Germ Scientists demonstrated the full functional regeneration of a salivary gland that reproduces the morphogenesis induced by reciprocal epithelial and mesenchymal interactions through the orthotopic transplantation of a bioengineered salivary gland germ as a regenerative organ replacement therapy. [Nat Commun] Full Article | Press Release |
PUBLICATIONS (Ranked by impact factor of the journal) |
Functional Lacrimal Gland Regeneration by Transplantation of a Bioengineered Organ Germ Researchers demonstrated orthotopic transplantation of bioengineered lacrimal gland germs into adult mice with an extra-orbital lacrimal gland defect, a mouse model that mimics the corneal epithelial damage caused by lacrimal gland dysfunction. [Nat Commun] Full Article | Press Release Integration of a Calcined Bovine Bone and BMSC-Sheet 3D Scaffold and the Promotion of Bone Regeneration in Large Defects Autologous Tenocyte Injection for the Treatment of Severe, Chronic Resistant Lateral Epicondylitis: A Pilot Study Human Endometrial Mesenchymal Stem Cells Modulate the Tissue Response and Mechanical Behavior of Polyamide Mesh Implants for Pelvic Organ Prolapse Repair Boosting Angiogenesis and Functional Vascularization in Injectable Dextran-Hyaluronic Acid Hydrogels by Endothelial-Like Mesenchymal Stromal Cells Stem Cell-Like Dog Placenta Cells Afford Neuroprotection against Ischemic Stroke Model via Heat Shock Protein Upregulation Impact of Failed Response to Novel Agent Induction in Autologous Stem Cell Transplantation for Multiple Myeloma Activation of Human Mesenchymal Stem Cells Impacts Their Therapeutic Abilities in Lung Injury by Increasing Interleukin (IL)-10 and IL-1RN Levels |
REVIEWS |
Cell Therapy for Multiple Sclerosis: An Evolving Concept with Implications for Other Neurodegenerative Diseases Efforts to develop stem-cell therapies for multiple sclerosis have been conventionally built on the principle of direct implantation of cells to replace oligodendrocytes, and therefore to regenerate myelin. Recent progress in understanding of disease processes in multiple sclerosis include observations that spontaneous myelin repair is far more widespread and successful than was previously believed, that loss of axons and neurons is more closely associated with progressive disability than is myelin loss, and that damage occurs diffusely throughout the CNS in gray and white matter, not just in discrete, isolated patches or lesions. [The Lancet] Abstract | Press Release Visit our reviews page to see a complete list of reviews in the cell, gene and immunotherapy research field. |
POLICY | ||||
Tales From the Shutdown: ClinicalTrials.gov Gets Exemption A plea from a federal lawmaker has allowed the National Institutes of Health to update a clinical trials database that had been frozen as a result of the U.S. government shutdown, according to The Boston Globe. [ScienceInsider] Editorial U.S. Senate Blocks House Plan to Exempt NIH From Shutdown New HHS Rule: Blood Stem Cells Aren’t for Sale Call for Change to Stem Cell Regulation
|
BUSINESS |
Researchers at University of Coimbra, Portugal, Win the Astellas European Foundation’s Inaugural Uro-Oncology Grant The Astellas European Foundation announced that Dr. Celia Gomes from the University of Coimbra has been selected as the recipient of the inaugural Uro-Oncology Grant 2013. The $150,000 award will support the University of Coimbra’s team looking at natural killer cell-based adoptive therapy targeting human bladder cancer stem cells: impact on tumor progression using a humanized orthotopic animal model. [PR Newswire Association LLC] Press Release TrakCel Accelerates Stem Cell Logistics Solution Development with Welsh Government Funding StemCells, Inc. Receives FDA Authorization of IND for Spinal Cord Injury BrainStorm Launches US Activities for Its Multi-Center ALS Clinical Trial Nanoparticle Stem Cell Replacement Therapy for Reflux Nephropathy Cellular Dynamics Issued U.S. Patent Covering iPSC Episomal Reprogramming Bone Therapeutics Receives Clearance for ALLOB® Phase I/IIa Trial Medistem Announces Preclinical Data on Type 1 Diabetes and Filing of Intellectual Property Geron Completes Divestiture of Stem Cell Assets |
NIH |
Center for Scientific Review; Notice of Closed Meeting |
EVENTS |
NEW Cell Culture World Congress 2014 February 25-27, 2014 Munich, Germany NEW 9th Annual World Stem Cells & Regenerative Medicine Congress 2014 Visit our events page to see a complete list of events in the cell, gene and immunotherapy community. |
SUBSCRIBER TOOLS: | |||
Profile Center | Connexon Publications | Article Submission | Contact Us |